Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |